Skip to main navigation Skip to search Skip to main content

Forensic mitochondrial DNA analysis in HIV-infected patients treated with nucleoside reverse transcriptase inhibitors

  • C. ROBINO
  • , C. COLLA
  • , A. BIGLINO
  • , M. DEGIOANNI
  • , Sarah GINO
  • , C. TORRE

Research output: Contribution to conferencePaper

Abstract

Hypervariable regions HV1 and HV2 of the mitochondrial DNA control region were sequenced in pre-therapy (serum) and post-therapy (saliva, hair) biological samples collected from HIV-infected patients (n = 13) treated with nucleoside reverse transcriptase inhibitors (NRTIs). Occurrence of length/point heteroplasmic mutations as a consequence of treatment with NRTIs was evaluated. The observed rate of length heteroplasmy in the analyzed samples was consistent with values previously reported in untreated subjects, whereas no evidence of point heteroplasmy in post-treatment tissue samples was seen.
Original languageEnglish
Pages501-502
Number of pages2
Publication statusPublished - 1 Jan 2009
Event23rd International ISFG Congress - Buenos Aires
Duration: 1 Jan 2009 → …

Conference

Conference23rd International ISFG Congress
CityBuenos Aires
Period1/01/09 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Mitochondrial DNA
  • Control region
  • Reverse transcriptase inhibitors
  • HIV
  • Hair

Fingerprint

Dive into the research topics of 'Forensic mitochondrial DNA analysis in HIV-infected patients treated with nucleoside reverse transcriptase inhibitors'. Together they form a unique fingerprint.

Cite this